{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:51:13Z","timestamp":1792036273459,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFE0190100"],"award-info":[{"award-number":["2021YFE0190100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFE0113600"],"award-info":[{"award-number":["2024YFE0113600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phymed.2026.158846","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:49:16Z","timestamp":1790783356000},"page":"158846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanistic insights into the therapeutic effects of Mongolian medicine Eligengurigumu-7 against non-alcoholic fatty liver disease via the PPAR signalling pathway"],"prefix":"10.1016","volume":"162","author":[{"given":"Congying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanze","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13835-w","article-title":"HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXR\u03b1 and PPAR\u03b1 dysregulation: implications for HIV-specific pathogenesis of NAFLD","volume":"7","author":"Agarwal","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts","volume":"17","author":"Alexander","year":"2019","journal-title":"BMC. Med."},{"key":"10.1016\/j.phymed.2026.158846_bib0003","series-title":"Clinical study on Mongolian medicine syndrome differentiation and treatment of non-alcoholic steatohepatitis. PhD thesis","author":"Alima","year":"2024"},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0004","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ptr.8404","article-title":"Effect of pomegranate peel consumption on liver enzymes, lipid profile, liver steatosis, and Hs-CRP in patients with non-alcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial","volume":"39","author":"Baghdadi","year":"2025","journal-title":"PhytOther Res."},{"issue":"3","key":"10.1016\/j.phymed.2026.158846_bib0005","first-page":"343","article-title":"Traditional Mongolian medicine: Past, present and future","volume":"14","author":"Bai","year":"2022","journal-title":"Chin. Herb. Med."},{"issue":"8","key":"10.1016\/j.phymed.2026.158846_bib0006","first-page":"2710","article-title":"The study of chemical constituents from Scabiosa comosa extract and their antioxidant activities","volume":"44","author":"Bao","year":"2022","journal-title":"Chin. Tradit. Pat. Med."},{"key":"10.1016\/j.phymed.2026.158846_bib0007","article-title":"Treatment of liver cancer: role of the traditional mongolian medicine","volume":"14","author":"Bao","year":"2022","journal-title":"Evid. Based. Complement. Alternat. Med."},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/17460751.3.2.217","article-title":"Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regeneration","volume":"3","author":"Bockamp","year":"2008","journal-title":"Regener. Med."},{"key":"10.1016\/j.phymed.2026.158846_bib0009","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.phymed.2026.158846_bib0010","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.phymed.2026.158846_bib0011","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/nu12051514","article-title":"Diet and nutrition status of mongolian adults","volume":"12","author":"Bromage","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.phymed.2026.158846_bib0012","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.3390\/nu13114062","article-title":"The contributions of food groups to the daily caloric intake in mongolian population: a mon-timeline study","volume":"13","author":"Byambasukh","year":"2021","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.phymed.2026.158846_bib0013","first-page":"1228","article-title":"Research progress on main active components of calculus bovis and their pharmacological effects on central nervous system","volume":"44","author":"Chen","year":"2022","journal-title":"Hebei J. Tradit. Chin. Med."},{"issue":"9","key":"10.1016\/j.phymed.2026.158846_bib0014","first-page":"179","article-title":"Analysis on components absorbed into blood of citri reticulatae pericarpium in rats based on sequential metabolism and UPLC-HRMS","volume":"29","author":"Chen","year":"2023","journal-title":"Chin. J. Exp. Tradit. Med. Form."},{"key":"10.1016\/j.phymed.2026.158846_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0016","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","article-title":"Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression","volume":"28","author":"Corbin","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"4","key":"10.1016\/j.phymed.2026.158846_bib0017","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of non-alcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.phymed.2026.158846_bib0018","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/ptr.6972","article-title":"Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial","volume":"35","author":"Darvish Damavandi","year":"2021","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2026.158846_bib0019","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12967-024-04942-0","article-title":"ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK-PPAR\u03b1-CPT1A axis","volume":"22","author":"Dong","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0021","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41467-020-20303-z","article-title":"Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH","volume":"12","author":"Dong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2026.158846_bib0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13020-019-0253-x","article-title":"Fecal medicines used in traditional medical system of China: a systematic review of their names, original species, traditional uses, and modern investigations","volume":"14","author":"Du","year":"2019","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/07315724.2018.1479990","article-title":"Effect of soy milk on metabolic status of patients with nonalcoholic fatty liver disease: a randomized clinical trial","volume":"38","author":"Eslami","year":"2019","journal-title":"J. Am. Coll. Nutr."},{"issue":"4","key":"10.1016\/j.phymed.2026.158846_bib0024","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"issue":"04","key":"10.1016\/j.phymed.2026.158846_bib0025","first-page":"494","article-title":"Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease(Version 2024)","volume":"27","author":"Fan","year":"2024","journal-title":"J. Pract. Hepatol."},{"key":"10.1016\/j.phymed.2026.158846_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2021.111904","article-title":"Changes in soil properties and salt tolerance of safflower in response to biochar-based metal oxide nanocomposites of magnesium and manganese","volume":"211","author":"Farhangi-Abriz","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"3","key":"10.1016\/j.phymed.2026.158846_bib0027","first-page":"221","article-title":"The association between food insulin index and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study","volume":"14","author":"Fatahi","year":"2021","journal-title":"Gastroenterol. Hepatol. Bed. Bench."},{"key":"10.1016\/j.phymed.2026.158846_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2019.101006","article-title":"ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: an updated review","volume":"77","author":"Feng","year":"2020","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.phymed.2026.158846_bib0029","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.phymed.2026.158846_bib0031","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"128","key":"10.1016\/j.phymed.2026.158846_bib0032","doi-asserted-by":"crossref","DOI":"10.3791\/56138","article-title":"The murine choline-deficient, ethionine-supplemented (CDE) diet model of chronic liver injury","author":"Gogoi-Tiwari","year":"2017","journal-title":"J. Vis. Exp."},{"issue":"10","key":"10.1016\/j.phymed.2026.158846_bib0034","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3390\/nu11102452","article-title":"A review of the potential benefits of increasing vitamin d status in mongolian adults through food fortification and vitamin d supplementation","volume":"11","author":"Grant","year":"2019","journal-title":"Nutrients"},{"issue":"24","key":"10.1016\/j.phymed.2026.158846_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"05","key":"10.1016\/j.phymed.2026.158846_bib0036","first-page":"639","article-title":"Study on hepatoprotective ingredients of mongolian medicine flos scabiosae based on the gray correlation method","volume":"32","author":"Han","year":"2021","journal-title":"Tradit. Med. Drug. Res. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158846_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.phymed.2026.158846_bib0039","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/hep.32066","article-title":"Salidroside activates the AMP-activated protein kinase pathway to suppress nonalcoholic steatohepatitis in mice","volume":"74","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2026.158846_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153412","article-title":"Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe-\/-mice: role of SIRT1","volume":"81","author":"Hua","year":"2021","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0041","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/st9.0000000000000017","article-title":"Quantitative comparison on the similarities and differences of Mongolian medicines in the treatment of liver diseases between China and Mongolia based on data mining","volume":"1","author":"Huang","year":"2023","journal-title":"Sci. Tradit. Chin. Med."},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0042","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12038-017-9675-8","article-title":"Maternal high-fat diet during pregnancy and lactation affects hepatic lipid metabolism in early life of offspring rat","volume":"42","author":"Huang","year":"2017","journal-title":"J. Biosci."},{"key":"10.1016\/j.phymed.2026.158846_bib0043","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-83112-0","article-title":"Omentin-1 mitigates non-alcoholic fatty liver disease by preserving autophagy through AMPK\u03b1\/mTOR signaling pathway","volume":"14","author":"Huang","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.phymed.2026.158846_bib0044","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.phymed.2026.158846_bib0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3350\/cmh.2020.0067","article-title":"Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH","volume":"26","author":"Hydes","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"issue":"18","key":"10.1016\/j.phymed.2026.158846_bib0046","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phymed.2026.158846_bib0047","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.07.007","article-title":"Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease","volume":"181","author":"Jump","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0048","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41420-024-02066-4","article-title":"EHHADH deficiency regulates pexophagy and accelerates tubulointerstitial injury in diabetic kidney disease","volume":"10","author":"Kan","year":"2024","journal-title":"Cell Death. Discov."},{"key":"10.1016\/j.phymed.2026.158846_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2020.101259","article-title":"The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"41","author":"Kazemi","year":"2020","journal-title":"Complement. Ther. Clin. Pract."},{"key":"10.1016\/j.phymed.2026.158846_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.phymed.2026.158846_bib0052","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2026.158846_bib0053","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-981-10-8684-7_11","article-title":"Animal models of non-alcoholic fatty liver diseases and its associated liver cancer","volume":"1061","author":"Lau","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.phymed.2026.158846_bib0054","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"International agency for research on cancer handbook working group. body fatness and cancer\u2013viewpoint of the IARC working group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phymed.2026.158846_bib0055","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2023.04.035","article-title":"A global research priority agenda to advance public health responses to fatty liver disease","volume":"79","author":"Lazarus","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2026.158846_bib0056","article-title":"Metabolism-associated gene signatures for FDG Avidity on PET\/CT and prognostic validation in hepatocellular carcinoma","volume":"12","author":"Lee","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.phymed.2026.158846_bib0057","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/cac2.12536","article-title":"Positive regulation of cell proliferation by the miR-1290-EHHADH axis in hepatocellular carcinoma","volume":"44","author":"Lee","year":"2024","journal-title":"Cancer Commun. (Lond)"},{"issue":"6","key":"10.1016\/j.phymed.2026.158846_bib0058","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2015.07.039","article-title":"CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt\/mTOR\/SREBP1c and P38\/PPAR\u03b1 pathways","volume":"63","author":"Li","year":"2015","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158846_bib0059","doi-asserted-by":"crossref","DOI":"10.26599\/FSHW.2024.9250102","article-title":"Hypolipidemic activity and mechanism of active components of Dracocephalum moldavica L. tea","volume":"14","author":"Li","year":"2025","journal-title":"Food Sci. Hum. Wellness."},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0060","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41467-019-09524-z","article-title":"Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPAR\u03b1","volume":"10","author":"Liang","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.phymed.2026.158846_bib0061","first-page":"104","article-title":"Quantitative research on the treatment of liver diseases with gurigumu","volume":"39","author":"Liu","year":"2023","journal-title":"Pharmacol. Clin. Chin. Mater. Med."},{"key":"10.1016\/j.phymed.2026.158846_bib0062","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/molecules29010012","article-title":"Design and synthesis of novel indole ethylamine derivatives as a lipid metabolism regulator targeting PPAR\u03b1\/CPT1 in AML12 cells","volume":"29","author":"Liu","year":"2024","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.phymed.2026.158846_bib0063","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phymed.2026.158846_bib0064","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nm.2332","article-title":"Brain PPAR-\u03b3 promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones","volume":"17","author":"Lu","year":"2011","journal-title":"Nat. Med."},{"issue":"03","key":"10.1016\/j.phymed.2026.158846_bib0065","first-page":"634","article-title":"Studies on HPLC fingerprint and the assay of seven compounds in mongolia medicinal materials flos scabiosa","volume":"41","author":"Ma","year":"2018","journal-title":"J. Chin. Med. Mater."},{"key":"10.1016\/j.phymed.2026.158846_bib0066","series-title":"Yi Yao Yue Di","first-page":"311","author":"Ma","year":"1985"},{"issue":"3","key":"10.1016\/j.phymed.2026.158846_bib0067","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jep.2012.03.028","article-title":"Neuropharmacological study of Dracocephalum moldavica L. (Lamiaceae) in mice: sedative effect and chemical analysis of an aqueous extract","volume":"141","author":"Mart\u00ednez-V\u00e1zquez","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"10.1016\/j.phymed.2026.158846_bib0068","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158846_bib0070","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158846_bib0072","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.3390\/ijms15058713","article-title":"Role of mitochondria in nonalcoholic fatty liver disease","volume":"15","author":"Nassir","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158846_bib0073","first-page":"72","volume":"1","year":"2020"},{"key":"10.1016\/j.phymed.2026.158846_bib0074","first-page":"683","volume":"1","year":"2020"},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0075","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phymed.2026.158846_bib0076","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/scipharm91040053","article-title":"Natural products for the treatment of non-alcoholic fatty liver disease: a comprehensive review","volume":"91","author":"Nucera","year":"2023","journal-title":"Sci. Pharm."},{"issue":"3","key":"10.1016\/j.phymed.2026.158846_bib0077","first-page":"288","article-title":"Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions","volume":"31","author":"Ofosu","year":"2018","journal-title":"Ann. Gastroenterol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0078","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.phymed.2026.158846_bib0079","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2026.158846_bib0080","series-title":"Medicine Standards of the Ministry of Health of the People's Republic of China - Mongolian Medicine Volume","first-page":"194","year":"1998"},{"key":"10.1016\/j.phymed.2026.158846_bib0081","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases hepatic triacylglycerol synthesis and improves insulin sensitivity","volume":"7","author":"Pinkosky","year":"2016","journal-title":"Nat. Commun."},{"issue":"10290","key":"10.1016\/j.phymed.2026.158846_bib0082","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0083","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026849","article-title":"High throughput sequencing and assessing disease risk","volume":"9","author":"Rego","year":"2019","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"key":"10.1016\/j.phymed.2026.158846_bib0084","article-title":"Identification and mechanism elucidation of medicative diet for food therapy XQCSY in NAFLD prevention: an integrative in silico study","volume":"1","author":"Ren","year":"2024","journal-title":"Food Med. Homol."},{"issue":"4","key":"10.1016\/j.phymed.2026.158846_bib0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOL.0000000000000878","article-title":"Bempedoic acid for nonalcoholic fatty liver disease: evidence and mechanisms of action","volume":"34","author":"Roglans","year":"2023","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0087","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the united states and the rest of the world","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin. Liver. Dis."},{"key":"10.1016\/j.phymed.2026.158846_bib0088","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","article-title":"The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease","volume":"20","author":"Sheng","year":"2021","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.phymed.2026.158846_bib0089","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in non-alcoholic fatty liver vs non-alcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"14","key":"10.1016\/j.phymed.2026.158846_bib0090","first-page":"1985","article-title":"Natural products as hepatoprotective agents-a comprehensive review of Clinical Trials","volume":"13","author":"S\u0142u\u017ca\u0142y","year":"2024","journal-title":"Plants (Basel)."},{"key":"10.1016\/j.phymed.2026.158846_bib0091","doi-asserted-by":"crossref","DOI":"10.1017\/jns.2020.39","article-title":"Associations between dietary total antioxidant capacity and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study","volume":"9","author":"Sohouli","year":"2020","journal-title":"J. Nutr. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0092","first-page":"137","article-title":"Improvement of quality standards for Mongolian medicine Gurigumu-7","volume":"27","author":"Sun","year":"2025","journal-title":"Mod. Chin. Med."},{"issue":"04","key":"10.1016\/j.phymed.2026.158846_bib0093","first-page":"567","article-title":"Simultaneous determination of 10 effective components in Effecive Part of uygur medicine dracocephalum moldavica L. by HPLC","volume":"43","author":"Tan","year":"2024","journal-title":"Herald. Med."},{"key":"10.1016\/j.phymed.2026.158846_bib0094","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4179852","article-title":"The effects of new selective PPAR\u03b1 Agonist CP775146 on Systematic lipid metabolism in obese mice and its potential mechanism","volume":"2020","author":"Tang","year":"2020","journal-title":"J. Diabetes. Res."},{"issue":"12","key":"10.1016\/j.phymed.2026.158846_bib0118","first-page":"1784","article-title":"Evaluation of animal models of fatty liver based on clinical disease and syndrome characteristics of traditional Chinese and western medicine","volume":"18","author":"Tian","year":"2023","journal-title":"World Chin. Med."},{"key":"10.1016\/j.phymed.2026.158846_bib0096","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/107434","article-title":"Misregulation of PPAR functioning and its pathogenic consequences associated with nonalcoholic fatty liver disease in human obesity","volume":"2012","author":"Videla","year":"2012","journal-title":"PPAR. Res."},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0097","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2026.158846_bib0098","article-title":"Role of selenium and 17\u03b2 oestradiol in modulating lipid accumulation in in vitro models of obesity and NAFLD","volume":"2","author":"Walsh","year":"2025","journal-title":"Food Med. Homol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158846_bib0099","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41419-020-2411-6","article-title":"TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice","volume":"11","author":"Wandrer","year":"2020","journal-title":"Cell Death. Dis."},{"issue":"6","key":"10.1016\/j.phymed.2026.158846_bib0100","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2026.158846_bib0101","article-title":"Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0102","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"8","key":"10.1016\/j.phymed.2026.158846_bib0103","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158846_bib0104","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.phrs.2016.02.028","article-title":"PPAR\u03b3 signaling and emerging opportunities for improved therapeutics","volume":"111","author":"Wang","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"07","key":"10.1016\/j.phymed.2026.158846_bib0105","first-page":"1347","article-title":"Rapid identification of chemical composition in safflower with UHPLC-LTQ-Orbitrap","volume":"40","author":"Wang","year":"2015","journal-title":"China J. Chin. Mater. Med."},{"issue":"6","key":"10.1016\/j.phymed.2026.158846_bib0106","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/ijms21062061","article-title":"PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"08","key":"10.1016\/j.phymed.2026.158846_bib0108","first-page":"1889","article-title":"Analysis of blood-entering components of Ganmao Qingre Granules based on UPLC-Q-TOF-MS\/MS technology","volume":"45","author":"Xia","year":"2022","journal-title":"J. Chin. Med. Mater."},{"key":"10.1016\/j.phymed.2026.158846_bib0109","article-title":"Diagnostic role of SPP1 and collagen IV in a rat model of type 2 diabetes mellitus with MASLD","volume":"14","author":"Xiao","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158846_bib0110","series-title":"Pharmacological Experimental Methodology","author":"Xu","year":"2002"},{"key":"10.1016\/j.phymed.2026.158846_bib0111","first-page":"34","article-title":"Comparison research of disease characteristics in three non-alcohol steatohepatitis models","volume":"33","author":"Xue","year":"2025","journal-title":"Acta. Lab. Anim. Sci. Sin."},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158846_bib0113","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phymed.2026.158846_bib0114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2026.158846_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112649","article-title":"Calculus bovis: A review of the traditional usages, origin, chemistry, pharmacological activities and toxicology","volume":"254","author":"Yu","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158846_bib0116","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1142\/S0192415X16500130","article-title":"Phytochemistry and Pharmacology of Carthamus tinctorius L","volume":"44","author":"Zhang","year":"2016","journal-title":"Am. J. Chin. Med."},{"issue":"24","key":"10.1016\/j.phymed.2026.158846_bib0117","first-page":"7795","article-title":"Potential Q-Markers of Simiao Yong'an Decoction based on \u201ccomponent absorbed into blood-efficacy of compound prescription-target pathway\u201d","volume":"53","author":"Zhou","year":"2022","journal-title":"Chin. Tradit. Herb. Drugs"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326010755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326010755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:33:44Z","timestamp":1792035224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326010755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":110,"alternative-id":["S0944711326010755"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158846","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into the therapeutic effects of Mongolian medicine Eligengurigumu-7 against non-alcoholic fatty liver disease via the PPAR signalling pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"158846"}}